[ad_1] The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, marking a significant advancement in enhancing global access to mpox testing. In an official statement, WHO said that the emergency use approval for the Alinity m MPXV assay, produced by Abbott Molecular Inc.,…
[ad_1] Viral hepatitis is 2nd-biggest infectious killer, narrowly trailing tuberculosis. (Representational) More than 3,500 people die from hepatitis viruses every day and the global toll is rising, the World Health Organization warned on Tuesday, calling for swift action to fight the second-largest infectious killer. New data from 187 countries showed that the number of deaths…
[ad_1] GENEVA: The World Health Organization on Friday denied Israel‘s claim that the WHO was in collusion with Hamas by ignoring Israeli evidence of the “military use” of hospitals in the Gaza Strip.WHO chief Tedros Adhanom Ghebreyesus also said that such accusations could endanger its staff on the ground.Tedros was responding to claims made Thursday…
[ad_1] NEW DELHI: Mental health may have become a focal point for both individuals and companies alike after Covid, but funding in the sector has ironically witnessed a huge plunge in 2023. Private equity funding in the mental healthtech space dropped significantly to $3 million, only about one-fourth of value invested in the previous year,…
[ad_1] Comments () Sort: NewestUpVotedOldestDiscussedDown Voted closecomments Count: 3000 X Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let’s work together to keep the…
[ad_1] BDR Pharma has introduced BDENZA (Enzalutamide), the world’s first oral solution, designed for the management of prostate cancer. BDENZA will be available at Rs 27,000 for 150mL, in an oral form to reduce the dosing frequency and toxicity associated with the excipients used in marketed formulation, and increase patient compliance, a company statement said….
